Skip to main content

Month: February 2026

Garrett Motion’s E-Cooling Compressor is Redefining Thermal Management Efficiency & Power for Electric Buses and Trucks in China

Truck and Bus HVAC integration leader Cling has awarded Garrett volume production of its breakthrough oil-free, foil bearing centrifugal compressor, with start of production in 2027Garrett’s E-Cooling CompressorTruck and Bus HVAC integration leader Cling has awarded Garrett volume production of its breakthrough oil-free, foil bearing centrifugal compressorGarrett and Cling E-Cooling Compressor series production project launchMr. Bohan Xu, Technical Center Director at Cling, and Mr. Leo Qian, VP China Customer Management at Garrett MotionPLYMOUTH, Mich. and ROLLE, Switzerland, Feb. 20, 2026 (GLOBE NEWSWIRE) — Garrett Motion Inc. (Nasdaq: GTX), a global leader in differentiated turbocharging and electrification technologies for automotive and industrial applications, announced the first serial award for its...

Continue reading

SSCP Lager Bidco AB (publ) – Interim report for fourth quarter 2025

Today SSCP Lager Bidco AB (publ) published an interim report for the fourth quarter, the report can be downloaded on www.logent.se or via the link below. For more information, please contact:Andrzej Kulik, CFO, telephone number: +46 738 15 67 00, andrzej.kulik@logent.se or Joel Engström, CEO, telephone number: +46 734 36 36 29, joel.engstrom@logent.se This press release was published on 20-02-2026 at 08:30 CET/CEST This information is of the type that SSCP Lager BidCo AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation, the Swedish Securities Markets Act and the Swedish Financial Instruments Trading Act. The information was submitted for publication through the agency of the contact persons set out above, on 20-02-2026 at 08:30 CET/CEST. About Logent GroupLogent is a comprehensive and independent logistics partner,...

Continue reading

RAMSAY SANTE : New step for Ramsay Santé in connection with Ramsay Health Care’s proposal to distribute its shareholding in Ramsay Santé to its shareholders

        PRESS RELEASE                Paris, 20 February 2026 New step for Ramsay Santé in connection with Ramsay Health Care’s proposal to distribute its shareholding in Ramsay Santé to its shareholders Ramsay Générale de Santé (“Ramsay Santé” or the “Group”) takes note of the proposal announced today (the “Proposal”) by Ramsay Health Care Limited (“RHC”) to distribute its 52.79% shareholding in Ramsay Santé to its own shareholders. The Proposal follows RHC’s review of its strategic options associated with its majority shareholding in Ramsay Santé, which the Group acknowledged in its press release dated 25 November 2025. This Proposal does not preclude the exploration of alternative options, which RHC states it is open to consider, including by engaging discussions with potentially interested third parties. The Board of Directors...

Continue reading

IMCD to acquire Willows Ingredients to strengthen its food & nutrition offering throughout Ireland and the UK

The acquisition will enhance IMCD’s capabilities in specialised health, sports and animal nutritionRotterdam, the Netherlands (20 February 2026) – IMCD N.V. (“IMCD” or “Company”), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today announces it has signed an agreement to acquire 100% of the shares in Willows Ingredients Group Limited (Willows Ingredients), a distributor of ingredients serving the food and nutrition sector with expertise in health, sports and animal nutrition. The company predominantly serves customers across Ireland and the UK. Willows Ingredients, headquartered in Ireland, will bring an established team of 26 employees and a long-standing reputation for technical support and strong customer relationships. In 2024, Willows Ingredients,...

Continue reading

BTS Group AB (publ) Year end report January – December 2025

2025 a disappointment, expected to go back to earnings growth in the first quarter 2026  October 1 – December 31, 2025Net sales amounted to MSEK 710 (796). Currency adjusted growth was –1%, where of –5% was organic. EBITA decreased 37% to MSEK 86 (136). EBITA margin was 12.1 (17.0)%. Profit after tax decreased 34% to MSEK 55 (84). Earnings per share decreased 34% to SEK 2.84 (4.30). Following changes in US tax legislation during 2025, BTS’s North American operations have gained expanded and partially retroactive tax deduction possibilities. These changes have had a significant positive impact on the reported income tax for the year which decreased by approximately MSEK 14, with full impact in the fourth quarter.January 1 – December 31, 2025Net sales amounted to MSEK 2,703 (2,802). Currency adjusted growth was 3%, where of –1% was...

Continue reading

DANONE: 2025: Another year of strong delivery

2025 Full-Year ResultsPress release – Paris, February 20, 2026 at 7:30am CET 2025: Another year of strong deliveryFY 2025 sales of €27,283m up +4.5% on a like-for-like (LFL) basis, with volume/mix up +2.7%, and price up +1.8% Q4 sales up +4.7% LFL, driven again by strong volume/mix, up +2.5%, and price up +2.1%Sustained momentum in Europe, driven by continued progress in EDP and solid performance in Adult Medical Nutrition and Waters Soft Q4 performance in North America, despite sustained momentum in High Protein and a solid Specialized Nutrition performance Closing a year of exceptional performance in China, North Asia & Oceania with strong Q4 in Specialized Nutrition and EDPRecurring operating margin up +44 basis points (bps) at 13.4% driven by further improvement in margin from operations while continuing to reinvest...

Continue reading

Umicore: Full Year Results 2025

Umicore Group key highlights for the full year 2025  Robust progress on CORE strategy executionStrong performance in foundation businesses Supported by Group-wide operational excellence efforts and a favorable metal price environment Executing mid-term plan in Battery Cathode Materials amid EV industry challengesSolid Group Key Figures as at 31 December 2025Revenues1 of € 3.6 billion Adjusted EBITDA of € 847 million and Adjusted EBITDA margin of 24.0% Adjusted EBIT of € 579 million and Adjusted EBIT margin of 16.5%Adjusted net profit (Group share) of € 288 million and adjusted EPS of € 1.20 ROCE of 15.7% Total recordable injury rate (TRIR) for own employees of 4.5 per 1 million exposure hoursEnhanced focus on capital discipline and performanceEfficiency measures of € 100 million, target achieved Capital expenditures...

Continue reading

Brunel Q4 2025 results: Stabilising performance with increased efficiency

Amsterdam, 20 February 2026 – Brunel International N.V. (Brunel; BRNL), a global specialist delivering customised project and workforce solutions to drive sustainable industry transformations through technology and talent, today announced its fourth quarter and full year results. Q4 2025 Key pointsRevenue of EUR 300.4 million, down 10% year-on-year (down 4% organically). Gross profit of EUR 52.8 million, down 15% year-on-year (down 11% organically). Underlying EBIT of EUR 11.6 million, demonstrating stabilisation compared to previous quarters down 20% year-on-year (down 15% organically). Underlying operating costs reduced to EUR 41.2 million, improved 13% year-on-year (improved 9% organically). Cost reduction programme announced at Q2 results fully implemented, additional cost savings programme of EUR 10 million launched in Q4, bringing...

Continue reading

EDF: 2025 annual results: Strong operational performance Positive cash flow, reducing net financial debt

2025 annual results Strong operational performancePositive cash flow, reducing net financial debt Performance supported by the highest nuclear power output in France in 6 years Electricity output: 515TWh (including 373TWh of nuclear in France) Sales: €113.3 bnEBITDA: €29.3 bnNet income – Group share: €8.4 bn Operating cash flow: €9.6 bn Net Financial Debt: €51.5 bn NFD/EBITDA: 1.8x – AED (1) / adjusted EBITDA: 2.6x Upgrade of EDF’s S&P rating to BBB+ stable in January 2026. At its meeting of 19 February 2026 chaired by Bernard Fontana, EDF’s Board of Directors approved the consolidated financial statements at 31 December 2025. Chairman and Chief Executive Officer of EDF Bernard Fontana said:“Safety, security and health are the Group’s priorities, to provide our customers with competitive, sovereign, low-carbon electricity....

Continue reading

Henriette Mersebach to step down as ALK’s head of R&D

ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced that Henriette Mersebach will step down as Executive Vice President, Research and Development, and as a member of the Board of Management, effective 23 February 2026. It has also been agreed that she will support the transition and assist with handover as needed. By mutual agreement, the CEO, Board of Directors and Henriette Mersebach have decided that it is the right time to appoint a new head of R&D with a different profile to advance ALK’s innovation efforts under the Allergy+ strategy. The aim of these efforts is to balance core‑business growth with expansion into adjacent allergy therapy areas via the internal pipeline, partnerships, and business development & licensing. All ongoing clinical development programmes will continue unchanged. Peter Halling, President &...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.